Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
4.950
+0.200 (4.21%)
Jan 22, 2026, 4:00 PM EST - Market closed
Artiva Biotherapeutics Employees
Artiva Biotherapeutics had 89 employees as of December 31, 2024. The number of employees increased by 46 or 106.98% compared to the previous year.
Employees
89
Change
46
Growth
106.98%
Revenue / Employee
n/a
Profits / Employee
-$889,753
Market Cap
121.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 89 | 46 | 106.98% |
| Dec 31, 2021 | 43 | 21 | 95.45% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 341 |
| Agenus | 316 |
| Karyopharm Therapeutics | 279 |
| Inovio Pharmaceuticals | 134 |
| Repare Therapeutics | 129 |
| Fortress Biotech | 101 |
| Verrica Pharmaceuticals | 71 |
| Acumen Pharmaceuticals | 61 |
ARTV News
- 1 day ago - Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability of AlloNK in NHL - GlobeNewsWire
- 7 days ago - Artiva Biotherapeutics: Upcoming Data Presentations May Bring Them Out Of Being Ignored - Seeking Alpha
- 2 months ago - Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK® - GlobeNewsWire
- 3 months ago - Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November - GlobeNewsWire
- 3 months ago - Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update - GlobeNewsWire
- 5 months ago - Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025 - GlobeNewsWire